Canada’s Apotex Donates Two Million Dosages of Hydroxychloroquine to the Public Health Agency of Canada
Supply will Support Clinical Trials and be Part of the National Emergency Strategic Stockpile
As researchers around the globe and across the country accelerate their efforts to study the effectiveness of hydroxychloroquine in treating COVID-19, Apotex, Canada’s largest pharmaceutical company and the only manufacturer of hydroxychloroquine in the country, announced a donation today of two million dosages of the medication to the federal government.